By Dr. Andrea Joy Smith
Philips Sonicare Global Clinical Advisory Board • Photo Courtesy of Philips Oral Healthcare
Philips Oral Healthcare has established a 12-member Global Clinical Advisory Board to provide scientific, clinical and strategic guidance across oral healthcare research, product development and innovation.
This Article is Sponsored by Dental Media Now
AMSTERDAM, Oct. 20, 2026, (DrAndreaJoySmith.com) — Health technology company Royal Philips has established the Philips Sonicare Global Clinical Advisory Board, bringing together 12 dental experts from the United States, Europe and China to advise its oral healthcare business.
The board will provide guidance on emerging trends, clinical research and product development while incorporating perspectives from dental professionals into Philips Oral Healthcare’s product planning.
Latest Blogs
•
Latest Blogs •
Members represent areas including periodontics, preventive care, digital dentistry, implantology, oral-systemic health, behavioral science, patient communication and oral and maxillofacial surgery.
“For more than 55 years, Philips has been an industry leader in oral care with a heritage rooted in health insights for improved outcomes and meaningful innovation. As part of a broader health technology company with deep clinical expertise across consumer health and professional health systems, Philips Oral Healthcare is uniquely positioned to connect dental professional insight with solutions that support better daily oral health. The Philips Sonicare Global Clinical Advisory Board helps us build on that legacy and continue developing evidence-led innovations that meet the needs of professionals and the people they care for,” said Francesco Grillo, Philips Global Business Unit Leader - Oral Healthcare.
The board includes Prof. Dr. Purnima Kumar of the University of Michigan School of Dentistry; Prof. Dr. Ann Eshenaur Spolarich of the Arizona School of Dentistry & Oral Health at A.T. Still University; Prof. Dr. Koula Asimakopoulou of Oxford Brookes University; and Prof. Dr. Iain Chapple of the University of Birmingham School of Dentistry.
Other members are Prof. Dr. Virginie Monnet-Corti of Aix-Marseille University and AP-HM Timone Hospital; Prof. Dr. Tim Joda of the University of Zurich Center for Dental Medicine; Prof. Dr. Xu Tongkai of Peking University School and Hospital of Stomatology; and Dr. Karolina Kopciewicz-Kozicka of Villanova Dental Clinic.
The board also includes Dr. Martina Kyjovská Čičváková of Pavol Jozef Šafárik University and University Hospital L. Pasteur; Prof. Dr. Ali Çekici of Istanbul University Faculty of Dentistry; Dr. Sarah Balaster, a U.S.-based Periodontist; and Prof. Dr. Dagmar Else Slot of the Academic Centre for Dentistry Amsterdam.
“Oral healthcare is entering a new era, shaped by prevention, personalization, digital innovation and a deeper understanding of how people build healthier routines. By bringing together experts from different clinical, academic and regional perspectives, the board will help Philips Sonicare look ahead, anticipate where the profession is moving, and translate expert insight into stronger innovations and ultimately better outcomes for consumers and patients,” said Andrew Bower, Business Category Leader, Dental Professional & Strategic Adjacencies, Philips Oral Healthcare.
According to Philips, the board is intended as a long-term collaboration, creating an ongoing exchange between its oral healthcare teams and external clinical and academic experts.
Royal Philips develops health technology products and services spanning diagnostic imaging, image-guided therapy, ultrasound, patient monitoring, enterprise informatics and personal health. The company reported approximately EUR 18 billion in sales in 2025 and employs about 63,700 people worldwide.
For more information, visit www.philips.com.
Source: Royal Philips
